Form 4: ResMed Inc. Executive Michael J. Rider Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Michael J. Rider, Global General Counsel of ResMed Inc., reports a disposition of shares for tax withholding and stock purchase plan activity.
Summary
- On June 4, 2024, Michael J. Rider, Global General Counsel of ResMed Inc., reported a transaction involving ResMed Common Stock.
- 267.244 shares were disposed of to the issuer for tax withholding purposes at a price of $206.33 per share.
- Following the transaction, Rider directly owns 6,444 shares of ResMed Common Stock, which includes 103.91 shares purchased through the ResMed Employee Stock Purchase Plan on April 30, 2024.
Sentiment
Score: 5
Explanation: The filing is a routine disclosure of insider transactions and does not inherently indicate positive or negative sentiment. It reflects standard compensation practices and regulatory compliance.
Industry Context
This filing is a routine disclosure related to insider transactions and is a standard practice for publicly traded companies like ResMed. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it relates to tax withholding and employee stock purchase plan activities.
Key Dates
| Date | Description |
|---|---|
| 06/01/2023 | Date of Restricted Stock Units grant related to tax withholding. |
| 04/30/2024 | Date of ResMed stock purchase through the Employee Stock Purchase Plan. |
| 06/04/2024 | Date of the reported transaction (disposition for tax withholding). |
| 06/10/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.